Back to search

Czechia· CZ-0280820

NEUROMULTIVIT NEO

A vitamin b1 in combination with vitamin b6 and/or vitamin b12 product containing benfotiamine + pyridoxine hydrochloride + cyanocobalamin, registered in Czechia by G.L. Pharma GmbH, Lannach. The same ATC class is registered in 7 of our 19 countries.

ATC A11DB

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedNEUROMULTIVIT NEOATCA11DBREGISTER NO.CZ-0280820PACKS LISTED0CHECKEDSeptember 28, 2026

Where it is registered

Benfotiamine + pyridoxine hydrochloride + cyanocobalamin is registered in 7 of 19 countries.

Countries holding a registration under ATC A11DB (vitamin b1 in combination with vitamin b6 and/or vitamin b12), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 7 of them publish a price we can compare per daily dose

Benfotiamine + pyridoxine hydrochloride + cyanocobalamin · ATC A11DB

7 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Icelandprice
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
BENFOTIAMINE + PYRIDOXINE HYDROCHLORIDE + CYANOCOBALAMIN
Manufacturer
G.L. Pharma GmbH, Lannach
Country
Czechia (CZ)
ATC code
A11DB
ATC class
Vitamin B1 in combination with vitamin B6 and/or vitamin B12
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Benfotiamine + pyridoxine hydrochloride + cyanocobalamin in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All benfotiamine + pyridoxine hydrochloride + cyanocobalamin products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Bulgaria · Бевит Трио, Бенфоневровит
  • Germany · Neuromultivit
  • Estonia · Neuromultivit
  • Hungary · Milgamma N, Neurogerlon Neo
  • Lithuania · Fenglavit, Milgamma N
  • Latvia · Fenglavit, Milgamma N
  • Poland · Besoltin, Invitaxon
  • Romania · Milgamma N, Neuromultivit Neuro
  • Slovenia · Neuromultivit
  • Slovakia · Milgamma N, Tiadel

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c9fb113a-e57a-40a3-8065-98dbb8b1e8b8
GET /v1/drugs/c9fb113a-e57a-40a3-8065-98dbb8b1e8b8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL FLM",
  "source": "sukl",
  "strength": "40MG/90MG/0,25MG",
  "pack_size": "100",
  "substance": "BENFOTIAMINE + PYRIDOXINE HYDROCHLORIDE + CYANOCOBALAMIN",
  "cz_kod_sukl": "0280820",
  "product_type": "CH",
  "substance_codes": "138,1230,425",
  "registration_state": "R",
  "registration_number": "86/579/23-C"
}

See everything about benfotiamine + pyridoxine hydrochloride + cyanocobalamin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.